Artificial intelligence spots COVID-19 in chest X-rays
PhaseBio Explodes 82% After-Hours On FDA Nod For Covid-19 Clinical Trial
Pediatric scoring scale helps surgeons decide whether to operate during COVID-19 delays
Moving Into The New "Normal"
Taking inventory of which drugs the world is using to treat COVID-19
Vaxine and Medytox – COVAX-19®
France, Italy, Belgium act to stop use of hydroxychloroquine for COVID-19 on safety fears
3 “Strong Buy” Biotech Stocks Under $5 With Explosive Upside Potential
Merck CEO Casts Doubt On ‘Very Aggressive’ Covid-19 Vaccine Timeline
Sorrento’s COVID-19 Antidote Could be a Game Changer, Says Analyst
Oxygen for all, during COVID-19 (coronavirus) and beyond
When and how to safely reopen the economy: How better data can help
Merck Joins Race For Covid-19 Vaccine; Shares Rise 4.4% In Pre-Market Trading
Peer-reviewed data shows remdesivir for COVID-19 improves time to recovery
COVID-19 Accurately Diagnosed by AI Model
WHO halts hydroxychloroquine trial in COVID-19 following safety concerns
7 "Perfect 10" Stocks to Buy Now
Agilent Up 5% On Solid Revenue Beat, But Top Analysts Stay Cautious
Gilead’s Remdesivir Most ‘Beneficial’ In Covid-19 Patients Who Need Extra Oxygen, Study Shows
Researchers define exactly what they saw in the first positive remdesivir study for Covid-19. But what's that worth to Gilead?
Succinct Summation of Week’s Events 5.22.20
These are some of the coronavirus vaccine candidates
Amarin Down 10% in Pre-Market On Generic Approval
Preventing ‘cytokine storm’ may ease severe COVID-19 symptoms
Some patients with bladder cancer ‘can’t wait’ for treatment during the COVID-19 pandemic
3 "Strong Buy" Biotech Stocks Under $5 With Massive Upside Potential
Markets Are Desperate for News About a COVID-19 Vaccines
Airway Therapeutics, Celonic Group partner to produce AT-100 as candidate for coronavirus
COVID Pandemic Highlights Need for Reform of US Healthcare
AstraZeneca Can Make Up To 1B Covid-19 Vaccine Doses, Signs First Supply Pacts